Ligand validation:4QI6

MAN: alpha-D-mannopyranose

MAN is a Ligand Of Interest in 4QI6 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4QI6_MAN_A_908	5%	53%	0.42	0.829	0.81	1.01	-	2	0	0	100%	1
4QI6_MAN_A_911	4%	52%	0.349	0.71	0.81	1.04	-	2	0	0	100%	1
4QI6_MAN_A_910	2%	56%	0.519	0.771	0.71	1	-	2	0	0	100%	1
4QI6_MAN_A_907	2%	54%	0.465	0.712	0.73	1.04	-	2	1	0	100%	1
4QI6_MAN_A_909	0%	53%	0.745	0.733	0.81	1.01	-	1	1	0	100%	1
4QI3_MAN_A_404	43%	39%	0.138	0.86	1.17	1.2	2	2	0	0	100%	1
5O2X_MAN_A_311	100%	66%	0.023	0.995	0.37	0.94	-	1	0	0	100%	1
7C3C_MAN_A_401	100%	65%	0.039	0.988	0.72	0.62	-	-	0	0	100%	1
5JUG_MAN_A_202	100%	57%	0.038	0.985	0.44	1.2	-	1	0	0	100%	0.4
1GAI_MAN_A_480	100%	75%	0.043	0.986	0.45	0.53	-	-	0	0	100%	1
5AGD_MAN_B_500	100%	38%	0.041	0.982	0.53	1.88	-	4	0	0	100%	0.5

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.